These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 26863983)

  • 21. Assessing subunit dependency of the Plasmodium proteasome using small molecule inhibitors and active site probes.
    Li H; van der Linden WA; Verdoes M; Florea BI; McAllister FE; Govindaswamy K; Elias JE; Bhanot P; Overkleeft HS; Bogyo M
    ACS Chem Biol; 2014 Aug; 9(8):1869-76. PubMed ID: 24918547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of Potent and Highly Selective Epoxyketone-Based Plasmodium Proteasome Inhibitors.
    Almaliti J; Fajtová P; Calla J; LaMonte GM; Feng M; Rocamora F; Ottilie S; Glukhov E; Boura E; Suhandynata RT; Momper JD; Gilson MK; Winzeler EA; Gerwick WH; O'Donoghue AJ
    Chemistry; 2023 Apr; 29(20):e202203958. PubMed ID: 36617500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in vivo anti-malarial activity of novel harmine-analog heat shock protein 90 inhibitors: a possible partner for artemisinin.
    Bayih AG; Folefoc A; Mohon AN; Eagon S; Anderson M; Pillai DR
    Malar J; 2016 Dec; 15(1):579. PubMed ID: 27903279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a Potent Inhibitor of the Plasmodium Proteasome with Reduced Mammalian Toxicity.
    LaMonte GM; Almaliti J; Bibo-Verdugo B; Keller L; Zou BY; Yang J; Antonova-Koch Y; Orjuela-Sanchez P; Boyle CA; Vigil E; Wang L; Goldgof GM; Gerwick L; O'Donoghue AJ; Winzeler EA; Gerwick WH; Ottilie S
    J Med Chem; 2017 Aug; 60(15):6721-6732. PubMed ID: 28696697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Susceptibilities of Ugandan Plasmodium falciparum Isolates to Proteasome Inhibitors.
    Garg S; Kreutzfeld O; Chelebieva S; Tumwebaze PK; Byaruhanga O; Okitwi M; Orena S; Katairo T; Nsobya SL; Conrad MD; Aydemir O; Legac J; Gould AE; Bayles BR; Bailey JA; Duffey M; Lin G; Kirkman LA; Cooper RA; Rosenthal PJ
    Antimicrob Agents Chemother; 2022 Oct; 66(10):e0081722. PubMed ID: 36094216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The proteasome as a target to combat malaria: hits and misses.
    Krishnan KM; Williamson KC
    Transl Res; 2018 Aug; 198():40-47. PubMed ID: 30009761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimalarials: Novel proteasome inhibitor combats malaria.
    Crunkhorn S
    Nat Rev Drug Discov; 2016 Apr; 15(4):232-3. PubMed ID: 27032831
    [No Abstract]   [Full Text] [Related]  

  • 28. Protocol for analysis of intracellular conversion of artezomib molecules into new proteasome inhibitors in Plasmodium falciparum parasites.
    Zhan W; Liu YJ; Kirkman LA; Lin G
    STAR Protoc; 2024 Mar; 5(1):102896. PubMed ID: 38363687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutation in the 26S proteasome regulatory subunit
    Gonçalves AF; Lima-Pinheiro A; Teixeira M; Cassiano GC; Cravo P; Ferreira PE
    Front Cell Infect Microbiol; 2024; 14():1342856. PubMed ID: 38404287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, Synthesis, and Optimization of Macrocyclic Peptides as Species-Selective Antimalaria Proteasome Inhibitors.
    Zhang H; Ginn J; Zhan W; Liu YJ; Leung A; Toita A; Okamoto R; Wong TT; Imaeda T; Hara R; Yukawa T; Michino M; Vendome J; Beuming T; Sato K; Aso K; Meinke PT; Nathan CF; Kirkman LA; Lin G
    J Med Chem; 2022 Jul; 65(13):9350-9375. PubMed ID: 35727231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ubiquitin Proteasome System as a Potential Drug Target for Malaria.
    Pereira PHS; Curra C; Garcia CRS
    Curr Top Med Chem; 2018; 18(5):315-320. PubMed ID: 29701143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cysteamine broadly improves the anti-plasmodial activity of artemisinins against murine blood stage and cerebral malaria.
    Moradin N; Torre S; Gauthier S; Tam M; Hawari J; Vandercruyssen K; De Spiegeleer B; Fortin A; Stevenson MM; Gros P
    Malar J; 2016 May; 15(1):260. PubMed ID: 27150250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Plasmodium falciparum ubiquitin-specific protease (PfUSP) is essential for parasite survival and its disruption enhances artemisinin efficacy.
    Arora P; Narwal M; Thakur V; Mukhtar O; Malhotra P; Mohmmed A
    Biochem J; 2023 Jan; 480(1):25-39. PubMed ID: 36511651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The A/T-specific DNA alkylating agent adozelesin inhibits Plasmodium falciparum growth in vitro and protects mice against Plasmodium chabaudi adami infection.
    Yanow SK; Purcell LA; Spithill TW
    Mol Biochem Parasitol; 2006 Jul; 148(1):52-9. PubMed ID: 16597469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Why is the Plasmodium falciparum hexose transporter a promising new drug target?
    Joët T; Morin C; Fischbarg J; Louw AI; Eckstein-Ludwig U; Woodrow C; Krishna S
    Expert Opin Ther Targets; 2003 Oct; 7(5):593-602. PubMed ID: 14498822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blocking Plasmodium falciparum development via dual inhibition of hemoglobin degradation and the ubiquitin proteasome system by MG132.
    Prasad R; Atul ; Kolla VK; Legac J; Singhal N; Navale R; Rosenthal PJ; Sijwali PS
    PLoS One; 2013; 8(9):e73530. PubMed ID: 24023882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and activity of a series of azole-based compounds with lactate dehydrogenase-directed anti-malarial activity.
    Cameron A; Read J; Tranter R; Winter VJ; Sessions RB; Brady RL; Vivas L; Easton A; Kendrick H; Croft SL; Barros D; Lavandera JL; Martin JJ; Risco F; García-Ochoa S; Gamo FJ; Sanz L; Leon L; Ruiz JR; Gabarró R; Mallo A; Gómez de las Heras F
    J Biol Chem; 2004 Jul; 279(30):31429-39. PubMed ID: 15117937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tripeptide analogues of MG132 as protease inhibitors.
    Pehere AD; Nguyen S; Garlick SK; Wilson DW; Hudson I; Sykes MJ; Morton JD; Abell AD
    Bioorg Med Chem; 2019 Jan; 27(2):436-441. PubMed ID: 30581047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Artemisinin resistance in rodent malaria--mutation in the AP2 adaptor μ-chain suggests involvement of endocytosis and membrane protein trafficking.
    Henriques G; Martinelli A; Rodrigues L; Modrzynska K; Fawcett R; Houston DR; Borges ST; d'Alessandro U; Tinto H; Karema C; Hunt P; Cravo P
    Malar J; 2013 Apr; 12():118. PubMed ID: 23561245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Profiling of the anti-malarial drug candidate SC83288 against artemisinins in Plasmodium falciparum.
    Duffey M; Sanchez CP; Lanzer M
    Malar J; 2018 Mar; 17(1):121. PubMed ID: 29558913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.